Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Sensenig Bethany | Chief Financial Officer | 3 | $0 | $11.0K | 2023-04-21 |
| Ventimiglia Samantha | Director | 3 | $0 | $0 | 2023-03-29 |
| Constantino Michael T. | Director | 8 | $73.7K | $0 | 2023-03-29 |
| RICE YEHUDA MICHAEL | Director | 3 | $0 | $0 | 2023-03-29 |
| Sirgo Mark A | Director | 25 | $950.2K | $0 | 2023-03-29 |
| JOHNSON LORIN K | Director | 9 | $0 | $0 | 2023-03-29 |
| Temperato John | Chief Executive Officer | 27 | $460.2K | $0 | 2023-03-27 |
| Sitar Edward J | Chief Financial Officer | 12 | $108.3K | $0 | 2021-09-14 |
| OrbiMed Israel BioFund GP Limited Partnership | Director, 10% Owner | 16 | $0 | $20.93M | 2021-06-25 |
| Darvish Nissim | Director, 10% Owner | 7 | $0 | $0 | 2020-10-30 |
| Laumas Sandeep | Director | 6 | $0 | $0 | 2020-07-06 |
| Proujansky Roy | Director | 1 | $0 | $0 | 2020-04-24 |
| Madan Jay P. | President | 1 | $0 | $0 | 2020-04-24 |
| Ramasastry Saira | Director | 1 | $0 | $0 | 2020-04-24 |
| MAIDA ANTHONY E III | Director | 1 | $0 | $0 | 2020-04-24 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Sensenig Bethany | Chief Financial Officer | S Sale | 2023-04-21 | 2023-04-21 | 9,100 | $1.21 | $11.0K | 41,077 | SEC↗ |
| Ventimiglia Samantha | Director | A Award | 2023-03-29 | 2023-03-31 | 7,885 | — | $0 | 7,885 | SEC↗ |
| Constantino Michael T. | Director | A Award | 2023-03-29 | 2023-03-31 | 7,885 | — | $0 | 10,911 | SEC↗ |
| JOHNSON LORIN K | Director | A Award | 2023-03-29 | 2023-03-31 | 7,885 | — | $0 | 12,125 | SEC↗ |
| RICE YEHUDA MICHAEL | Director | A Award | 2023-03-29 | 2023-03-31 | 7,885 | — | $0 | 7,885 | SEC↗ |
| Sirgo Mark A | Director | A Award | 2023-03-29 | 2023-03-31 | 7,885 | — | $0 | 85,907 | SEC↗ |
| Temperato John | Chief Executive Officer | A Award | 2023-03-27 | 2023-03-29 | 68,815 | — | $0 | 140,192 | SEC↗ |
| Sensenig Bethany | Chief Financial Officer | A Award | 2023-03-27 | 2023-03-29 | 50,177 | — | $0 | 50,177 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy | 2022-07-06 | 2022-07-08 | 125,000 | $0.23 | $28.8K | 1,427,522 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2022-07-01 | 2022-07-06 | 175,000 | $0.25 | $43.8K | 1,454,045 | SEC↗ |
| Sirgo Mark A | Director | A Award | 2022-07-01 | 2022-07-22 | 175,000 | $0.25 | $43.8K | 1,560,428 | SEC↗ |
| Constantino Michael T. | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 142,509 | — | $0 | 142,509 | SEC↗ |
| JOHNSON LORIN K | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 142,509 | — | $0 | 142,509 | SEC↗ |
| RICE YEHUDA MICHAEL | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 142,509 | — | $0 | 142,509 | SEC↗ |
| Ventimiglia Samantha | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 142,509 | — | $0 | 142,509 | SEC↗ |
| Sirgo Mark A | Director | A Award deriv | 2022-06-22 | 2022-06-23 | 142,509 | — | $0 | 142,509 | SEC↗ |
| Constantino Michael T. | Director | P Buy | 2022-05-23 | 2022-05-24 | 16,000 | $0.48 | $7.7K | 60,509 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2022-05-18 | 2022-05-19 | 106,383 | $0.47 | $50.0K | 1,385,428 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy | 2022-05-18 | 2022-05-19 | 50,000 | $0.45 | $22.5K | 1,302,522 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy | 2022-03-03 | 2022-03-04 | 100,000 | $0.56 | $56.0K | 1,252,522 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2022-03-03 | 2022-03-07 | 86,450 | $0.58 | $50.1K | 1,279,045 | SEC↗ |
| Temperato John | Chief Executive Officer | A Award deriv | 2022-02-21 | 2022-02-23 | 2,479,060 | — | $0 | 2,479,060 | SEC↗ |
| Sensenig Bethany | Chief Financial Officer | A Award deriv | 2022-01-18 | 2022-01-18 | 1,300,000 | — | $0 | 1,300,000 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-12-02 | 2021-12-03 | 50,000 | $0.89 | $44.5K | 1,242,595 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy | 2021-11-18 | 2021-11-19 | 50,000 | $1.05 | $52.5K | 1,152,522 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-11-18 | 2021-11-22 | 20,000 | $1.06 | $21.2K | 1,192,595 | SEC↗ |
| Ventimiglia Samantha | Director | A Award deriv | 2021-10-01 | 2021-10-04 | 150,000 | $1.29 | $193.5K | 150,000 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | P Buy | 2021-09-14 | 2021-09-15 | 15,000 | $1.22 | $18.3K | 194,338 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-09-07 | 2021-09-08 | 73,529 | $1.36 | $100.0K | 1,172,595 | SEC↗ |
| Constantino Michael T. | Director | P Buy | 2021-08-24 | 2021-08-26 | 18,000 | $1.14 | $20.5K | 52,108 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-08-20 | 2021-08-23 | 25,000 | $1.10 | $27.5K | 1,099,066 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy | 2021-08-18 | 2021-08-19 | 25,000 | $1.05 | $26.3K | 1,102,522 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | S Sale | 2021-06-25 | 2021-06-25 | 15,989,876 | $1.21 | $19.35M | 8,565,974 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | S Sale | 2021-06-24 | 2021-06-25 | 319,255 | $1.38 | $440.6K | 24,555,850 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | S Sale | 2021-06-23 | 2021-06-25 | 841,650 | $1.36 | $1.14M | 24,875,105 | SEC↗ |
| Constantino Michael T. | Director | A Award deriv | 2021-06-22 | 2021-06-23 | 90,000 | — | $0 | 90,000 | SEC↗ |
| JOHNSON LORIN K | Director | A Award deriv | 2021-06-22 | 2021-06-23 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Sirgo Mark A | Director | A Award deriv | 2021-06-22 | 2021-06-23 | 90,000 | — | $0 | 90,000 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | X Exercise deriv | 2021-05-11 | 2021-05-13 | 12,500 | — | $0 | 37,500 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | X Exercise deriv | 2021-05-11 | 2021-05-13 | 19,444 | — | $0 | 80,556 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | X Exercise | 2021-05-11 | 2021-05-13 | 12,500 | $0.70 | $8.8K | 25,729,255 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | X Exercise | 2021-05-11 | 2021-05-13 | 19,444 | $0.62 | $12.1K | 25,748,699 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | P Buy | 2021-04-05 | 2021-04-06 | 50,000 | $1.00 | $50.0K | 179,338 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy | 2021-04-05 | 2021-04-06 | 100,000 | $1.00 | $100.0K | 1,077,522 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2021-04-05 | 2021-04-06 | 300,000 | $1.00 | $300.0K | 1,074,066 | SEC↗ |
| RICE YEHUDA MICHAEL | Director | A Award deriv | 2021-02-26 | 2021-03-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Temperato John | Chief Executive Officer | A Award deriv | 2021-02-04 | 2021-02-05 | 1,309,626 | — | $0 | 1,309,626 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | A Award deriv | 2021-02-04 | 2021-02-05 | 477,468 | — | $0 | 477,468 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | P Buy | 2020-12-15 | 2020-12-17 | 61,538 | $0.65 | $40.0K | 129,338 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2020-12-15 | 2020-12-17 | 230,769 | $0.65 | $150.0K | 774,066 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy | 2020-12-15 | 2020-12-17 | 153,846 | $0.65 | $100.0K | 977,522 | SEC↗ |
| Temperato John | Chief Executive Officer | J Other deriv | 2020-11-27 | 2020-12-01 | 639,655 | — | $0 | 639,655 | SEC↗ |
| Temperato John | Chief Executive Officer | J Other deriv | 2020-11-27 | 2020-12-01 | 650,000 | — | $0 | 0 | SEC↗ |
| Temperato John | Chief Executive Officer | J Other deriv | 2020-11-27 | 2020-12-01 | 639,655 | — | $0 | 310,345 | SEC↗ |
| Temperato John | Chief Executive Officer | J Other deriv | 2020-11-27 | 2020-12-01 | 650,000 | — | $0 | 650,000 | SEC↗ |
| Temperato John | Chief Executive Officer | A Award | 2020-11-27 | 2020-12-01 | 203,667 | — | $0 | 823,676 | SEC↗ |
| Temperato John | Chief Executive Officer | J Other | 2020-10-30 | 2020-11-03 | 4,513 | — | $0 | 620,009 | SEC↗ |
| Sirgo Mark A | Director | J Other | 2020-10-30 | 2020-11-03 | 4,513 | — | $0 | 543,297 | SEC↗ |
| Darvish Nissim | Director, 10% Owner | J Other | 2020-10-30 | 2020-11-03 | 1,943,734 | — | $0 | 25,716,755 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | J Other | 2020-10-30 | 2020-11-03 | 1,943,734 | — | $0 | 25,716,755 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2020-09-11 | 2020-09-14 | 21,485 | $0.65 | $14.0K | 21,485 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2020-09-11 | 2020-09-14 | 77,000 | $0.68 | $52.4K | 538,784 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2020-09-10 | 2020-09-14 | 50,000 | $0.60 | $30.0K | 461,784 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy | 2020-08-21 | 2020-08-24 | 70,000 | $0.69 | $48.3K | 615,496 | SEC↗ |
| Constantino Michael T. | Director | P Buy | 2020-08-20 | 2022-03-21 | 26,509 | $0.75 | $19.9K | 26,509 | SEC↗ |
| Constantino Michael T. | Director | P Buy | 2020-08-20 | 2020-08-21 | 34,108 | $0.75 | $25.6K | 34,108 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy | 2020-08-17 | 2020-08-17 | 35,000 | $0.57 | $19.9K | 545,496 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2020-08-17 | 2020-08-18 | 100,000 | $0.56 | $56.0K | 411,784 | SEC↗ |
| Constantino Michael T. | Director | A Award deriv | 2020-07-06 | 2020-07-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Darvish Nissim | Director, 10% Owner | A Award deriv | 2020-07-06 | 2020-07-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | A Award deriv | 2020-07-06 | 2020-07-08 | 225,000 | — | $0 | 775,000 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | A Award deriv | 2020-07-06 | 2020-07-08 | 550,000 | — | $0 | 550,000 | SEC↗ |
| JOHNSON LORIN K | Director | A Award deriv | 2020-07-06 | 2020-07-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Laumas Sandeep | Director | A Award deriv | 2020-07-06 | 2020-07-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Sirgo Mark A | Director | A Award deriv | 2020-07-06 | 2020-07-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Temperato John | Chief Executive Officer | A Award deriv | 2020-07-06 | 2020-07-08 | 950,000 | — | $0 | 950,000 | SEC↗ |
| Temperato John | Chief Executive Officer | A Award deriv | 2020-07-06 | 2020-07-08 | 650,000 | — | $0 | 1,600,000 | SEC↗ |
| Temperato John | Chief Executive Officer | C Conversion deriv | 2020-06-30 | 2020-07-02 | 2,714 | — | $0 | 0 | SEC↗ |
| JOHNSON LORIN K | Director | C Conversion deriv | 2020-06-30 | 2020-07-02 | 848 | — | $0 | 0 | SEC↗ |
| Sirgo Mark A | Director | C Conversion deriv | 2020-06-30 | 2020-07-02 | 2,544 | — | $0 | 0 | SEC↗ |
| Darvish Nissim | Director, 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 67,865 | — | $0 | 0 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | C Conversion deriv | 2020-06-30 | 2020-07-02 | 67,865 | — | $0 | 0 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | C Conversion deriv | 2020-06-30 | 2020-07-02 | 678 | — | $0 | 0 | SEC↗ |
| Laumas Sandeep | Director | C Conversion deriv | 2020-06-30 | 2020-07-02 | 424 | — | $0 | 0 | SEC↗ |
| Temperato John | Chief Executive Officer | A Award | 2020-06-30 | 2020-07-01 | 189,655 | — | $0 | 239,096 | SEC↗ |
| Temperato John | Chief Executive Officer | C Conversion | 2020-06-30 | 2020-07-02 | 271,400 | — | $0 | 510,496 | SEC↗ |
| JOHNSON LORIN K | Director | C Conversion | 2020-06-30 | 2020-07-02 | 84,800 | — | $0 | 84,800 | SEC↗ |
| Sirgo Mark A | Director | C Conversion | 2020-06-30 | 2020-07-02 | 254,400 | — | $0 | 311,784 | SEC↗ |
| Darvish Nissim | Director, 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 6,786,500 | — | $0 | 23,773,021 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | C Conversion | 2020-06-30 | 2020-07-02 | 6,786,500 | — | $0 | 23,773,021 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | C Conversion | 2020-06-30 | 2020-07-02 | 67,800 | — | $0 | 67,800 | SEC↗ |
| Laumas Sandeep | Director | C Conversion | 2020-06-30 | 2020-07-02 | 42,400 | — | $0 | 60,400 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy | 2020-06-15 | 2020-06-15 | 10,000 | $0.60 | $6.0K | 49,441 | SEC↗ |
| Sirgo Mark A | Director | P Buy | 2020-06-15 | 2020-06-16 | 17,943 | $0.60 | $10.8K | 57,384 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | P Buy deriv | 2020-05-04 | 2021-03-19 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | P Buy deriv | 2020-05-04 | 2021-03-19 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | P Buy deriv | 2020-05-04 | 2020-05-04 | 678 | — | $0 | 67,800 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | P Buy deriv | 2020-05-04 | 2020-05-04 | 678 | — | $0 | 67,800 | SEC↗ |
| Laumas Sandeep | Director | P Buy deriv | 2020-05-04 | 2020-05-04 | 424 | — | $0 | 42,400 | SEC↗ |
| Laumas Sandeep | Director | P Buy deriv | 2020-05-04 | 2020-05-04 | 424 | — | $0 | 42,400 | SEC↗ |
| JOHNSON LORIN K | Director | P Buy deriv | 2020-05-04 | 2020-05-04 | 848 | — | $0 | 84,800 | SEC↗ |
| JOHNSON LORIN K | Director | P Buy deriv | 2020-05-04 | 2020-05-04 | 848 | — | $0 | 84,800 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy deriv | 2020-05-04 | 2020-05-04 | 2,714 | — | $0 | 271,400 | SEC↗ |
| Temperato John | Chief Executive Officer | P Buy deriv | 2020-05-04 | 2020-05-04 | 2,714 | — | $0 | 271,400 | SEC↗ |
| Sirgo Mark A | Director | P Buy deriv | 2020-05-04 | 2020-05-04 | 2,544 | — | $0 | 254,400 | SEC↗ |
| Sirgo Mark A | Director | P Buy deriv | 2020-05-04 | 2020-05-04 | 2,544 | — | $0 | 254,400 | SEC↗ |
| Darvish Nissim | Director, 10% Owner | P Buy deriv | 2020-05-04 | 2020-05-05 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| Darvish Nissim | Director, 10% Owner | P Buy deriv | 2020-05-04 | 2020-05-05 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | P Buy deriv | 2020-05-04 | 2020-05-05 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | P Buy deriv | 2020-05-04 | 2020-05-05 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | A Award | 2020-04-30 | 2021-03-19 | 18,930,255 | — | $0 | 18,930,255 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | A Award deriv | 2020-04-30 | 2020-05-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Temperato John | Chief Executive Officer | A Award deriv | 2020-04-30 | 2020-05-04 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Sirgo Mark A | Director | A Award deriv | 2020-04-30 | 2020-05-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | A Award deriv | 2020-04-30 | 2020-05-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Darvish Nissim | Director, 10% Owner | A Award deriv | 2020-04-30 | 2020-05-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Madan Jay P. | President | A Award deriv | 2020-04-24 | 2020-05-04 | 203,406 | — | $0 | 203,406 | SEC↗ |
| Ramasastry Saira | Director | A Award deriv | 2020-04-24 | 2020-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MAIDA ANTHONY E III | Director | A Award deriv | 2020-04-24 | 2020-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Sitar Edward J | Chief Financial Officer | A Award deriv | 2020-04-24 | 2020-05-04 | 176,156 | — | $0 | 176,156 | SEC↗ |
| Laumas Sandeep | Director | A Award deriv | 2020-04-24 | 2020-05-04 | 389,294 | — | $0 | 389,294 | SEC↗ |
| JOHNSON LORIN K | Director | A Award deriv | 2020-04-24 | 2020-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Proujansky Roy | Director | A Award deriv | 2020-04-24 | 2020-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |